Skip to main content

Find Clinical Trials

Home
Conditions
Pharmacokinetics of ASP2408

Clinical trial condition

Pharmacokinetics of ASP2408

Explore clinical trials studying Pharmacokinetics of ASP2408. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Pharmacokinetics of ASP2408 trial results

Completed

A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

NCT02140125

Conditions: Healthy, Pharmacokinetics of ASP2408
Locations: Kyushu, Japan

View Trial Details

Completed

A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections

NCT02150070

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +8 more
Locations: Parexel International Baltimore, Maryland, United States

View Trial Details

Completed

A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects

NCT02125435

Conditions: Healthy Subjects, Pharmacokinetics of ASP2408
Locations: PAREXEL International Baltimore, Maryland, United States

View Trial Details

Completed

A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate

NCT02052375

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +8 more
Locations: Pinnacle Research Group, LLC Anniston, Alabama, United States

Altoona Center for Clinical Research Duncansville, Pennsylvania, United States

Metroplex Clinical Research Center, LLC Dallas, Texas, United States

View Trial Details